Klinique Med Revenue vs. Return On Asset

KLINIQ Stock   32.75  1.25  3.97%   
Based on the measurements of profitability obtained from Klinique Med's financial statements, The Klinique Med may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Klinique Med's ability to earn profits and add value for shareholders.
For Klinique Med profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Klinique Med to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well The Klinique Med utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Klinique Med's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of The Klinique Med over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Klinique Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Klinique Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Klinique Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Klinique Med Return On Asset vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Klinique Med's current stock value. Our valuation model uses many indicators to compare Klinique Med value to that of its competitors to determine the firm's financial worth.
The Klinique Med is considered the number one company in revenue category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The ratio of Revenue to Return On Asset for The Klinique Med is about  12,391,390,933 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Klinique Med by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Klinique Med's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Klinique Revenue vs. Competition

The Klinique Med is considered the number one company in revenue category among its peers. Market size based on revenue of Personal Services industry is now estimated at about 96.2 Billion. Klinique Med claims roughly 1.49 Billion in revenue contributing just under 2% to equities listed under Personal Services industry.

Klinique Return On Asset vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Klinique Med

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
1.49 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Klinique Med

Return On Asset

 = 

Net Income

Total Assets

 = 
0.12
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Klinique Return On Asset Comparison

Klinique Med is currently under evaluation in return on asset category among its peers.

Klinique Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Klinique Med. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Klinique Med position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Klinique Med's important profitability drivers and their relationship over time.

Use Klinique Med in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klinique Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klinique Med will appreciate offsetting losses from the drop in the long position's value.

Klinique Med Pair Trading

The Klinique Med Pair Trading Analysis

The ability to find closely correlated positions to Klinique Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klinique Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klinique Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The Klinique Med to buy it.
The correlation of Klinique Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klinique Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klinique Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klinique Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Klinique Med position

In addition to having Klinique Med in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Driverless Cars Thematic Idea Now

Driverless Cars
Driverless Cars Theme
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Klinique Stock

To fully project Klinique Med's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Klinique Med at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Klinique Med's income statement, its balance sheet, and the statement of cash flows.
Potential Klinique Med investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Klinique Med investors may work on each financial statement separately, they are all related. The changes in Klinique Med's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Klinique Med's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.